Context Therapeutics announces bispecific antibody clinical candidate to treat CLDN6+ cancers

Sign In \| Register \| About Menlo Park \| Contact Us
Menlo Park, CA September 01, 2020 1:28pm 7-Day Forecast \| Traffic

- Bagels
- Bakery
- Barbecue
- Burgers
- Chinese
- Coffee House
- Continental
- Deli
- Fast Food
- French
- Ice Cream / Frozen Yogurt
- International
- Italian
- Japanese
- Mexican
- Pizza
- Sandwiches
- Seafood
- Steak Chops
- Sushi
- Wine
- Bars and Lounges
- Museum
- Family Fun
- Arts & Culture
- Parks
- Annual Events
- Golf
- Classifieds
- Cars
- Forums
- Coupons
- News Archives
- Contests
- Jobs

Recent Quotes

My Watchlist

Indicators

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Search Hotels in Menlo Park

Find A Business

or Browse Listings

Context Therapeutics announces bispecific antibody clinical candidate to treat CLDN6+ cancers